698P A dose-response study of ramucirumab treatment in patients with gastric cancer/gastroesophageal junction adenocarcinoma: primary results of 4 dosing regimens in the phase 2 trial I4T-MC-JVDB.
Ajani, J Udrea, A Sarosiek, T Shenker, M Morgan, C Pikiel, J Wojcik, E Swinson, D Joseph, M Luft, A
Ajani, J
Udrea, A
Sarosiek, T
Shenker, M
Morgan, C
Pikiel, J
Wojcik, E
Swinson, D
Joseph, M
Luft, A
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2017-09
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
698P A dose-response study of ramucirumab treatment in patients with gastric cancer/gastroesophageal junction adenocarcinoma: primary results of 4 dosing regimens in the phase 2 trial I4T-MC-JVDB. 2017, 28(suppl_5): Ann Oncol